Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 5
2016 10
2017 7
2018 4
2019 5
2020 5
2021 12
2022 6
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
First Clinical Results for PSMA-Targeted α-Therapy Using 225Ac-PSMA-I&T in Advanced-mCRPC Patients.
Zacherl MJ, Gildehaus FJ, Mittlmeier L, Böning G, Gosewisch A, Wenter V, Unterrainer M, Schmidt-Hegemann N, Belka C, Kretschmer A, Casuscelli J, Stief CG, Unterrainer M, Bartenstein P, Todica A, Ilhan H. Zacherl MJ, et al. Among authors: wenter v. J Nucl Med. 2021 May 10;62(5):669-674. doi: 10.2967/jnumed.120.251017. Epub 2020 Oct 2. J Nucl Med. 2021. PMID: 33008928 Free article.
Preoperative Imaging with [18F]-Fluorocholine PET/CT in Primary Hyperparathyroidism.
Dekorsy FJ, Beyer L, Spitzweg C, Schmidmaier R, Todica A, Trupka A, Cyran CC, Berger F, Ladurner R, Zimmermann P, Knösel T, Bartenstein P, Lottspeich C, Wenter V. Dekorsy FJ, et al. Among authors: wenter v. J Clin Med. 2022 May 23;11(10):2944. doi: 10.3390/jcm11102944. J Clin Med. 2022. PMID: 35629070 Free PMC article.
Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures.
Wang K, Schütze I, Gulde S, Bechmann N, Richter S, Helm J, Lauseker M, Maurer J, Reul A, Spoettl G, Klink B, William D, Knösel T, Friemel J, Bihl M, Weber A, Fankhauser M, Schober L, Vetter D, Broglie Däppen M, Ziegler CG, Ullrich M, Pietzsch J, Bornstein SR, Lottspeich C, Kroiss M, Fassnacht M, Wenter VUJ, Ladurner R, Hantel C, Reincke M, Eisenhofer G, Grossman AB, Pacak K, Beuschlein F, Auernhammer CJ, Pellegata NS, Nölting S. Wang K, et al. Among authors: wenter vuj. Endocr Relat Cancer. 2022 May 9;29(6):285-306. doi: 10.1530/ERC-21-0355. Endocr Relat Cancer. 2022. PMID: 35324454
Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T/[225Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging.
Delker A, Schleske M, Liubchenko G, Berg I, Zacherl MJ, Brendel M, Gildehaus FJ, Rumiantcev M, Resch S, Hürkamp K, Wenter V, Unterrainer LM, Bartenstein P, Ziegler SI, Beyer L, Böning G. Delker A, et al. Among authors: wenter v. Eur J Nucl Med Mol Imaging. 2023 Apr;50(5):1280-1290. doi: 10.1007/s00259-022-06092-1. Epub 2023 Jan 11. Eur J Nucl Med Mol Imaging. 2023. PMID: 36629878 Free PMC article.
L-type amino acid transporter (LAT) 1 expression in 18F-FET-negative gliomas.
Vettermann FJ, Diekmann C, Weidner L, Unterrainer M, Suchorska B, Ruf V, Dorostkar M, Wenter V, Herms J, Tonn JC, Bartenstein P, Riemenschneider MJ, Albert NL. Vettermann FJ, et al. Among authors: wenter v. EJNMMI Res. 2021 Dec 14;11(1):124. doi: 10.1186/s13550-021-00865-9. EJNMMI Res. 2021. PMID: 34905134 Free PMC article.
[Radionuclide therapy and diagnostics in urology].
Fendler WP, Wenter V, Stief CG, Gratzke C, Bartenstein P. Fendler WP, et al. Among authors: wenter v. Urologe A. 2015 Jul;54(7):1025-35; quiz 1036-7. doi: 10.1007/s00120-014-3730-y. Urologe A. 2015. PMID: 26162277 German.
Feasibility of [68Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma.
Unterrainer LM, Lindner S, Eismann L, Casuscelli J, Gildehaus FJ, Bui VN, Albert NL, Holzgreve A, Beyer L, Todica A, Brendel M, Cyran CC, Karl A, Stief CG, Ledderose ST, Unterrainer M, Bartenstein P, Wenter V, Kretschmer A. Unterrainer LM, et al. Among authors: wenter v. Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3571-3580. doi: 10.1007/s00259-022-05761-5. Epub 2022 Mar 24. Eur J Nucl Med Mol Imaging. 2022. PMID: 35325283 Free PMC article.
Dosimetry and optimal scan time of [18F]SiTATE-PET/CT in patients with neuroendocrine tumours.
Beyer L, Gosewisch A, Lindner S, Völter F, Mittlmeier LM, Tiling R, Brendel M, Cyran CC, Unterrainer M, Rübenthaler J, Auernhammer CJ, Spitzweg C, Böning G, Gildehaus FJ, Jurkschat K, Wängler C, Wängler B, Schirrmacher R, Wenter V, Todica A, Bartenstein P, Ilhan H. Beyer L, et al. Among authors: wenter v. Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3571-3581. doi: 10.1007/s00259-021-05351-x. Epub 2021 Apr 29. Eur J Nucl Med Mol Imaging. 2021. PMID: 33928401 Free PMC article.
51 results